# Diagnostics firm Bio-Rad in talks to merge with Qiagen – WSJ
Author:  Pal Sinha, Barnali 
Author URL: https://financedigest.com/author/pal-sinha-barnali
Published: 2022-10-11
Category: NEWS
Category URL: https://financedigest.com/category/news
Meta Title: Bio-Rad Labs in talks to merge with Qiagen NV: WSJ report
Meta Description: California-based diagnostic company Bio-Rad Labs and Qiagen NV in merger talks, deal worth over $10bn, potential big move in healthcare testing domain.
URL: https://financedigest.com/diagnostics-firm-bio-rad-in-talks-to-merge-with-qiagen-wsjhtml

![undefined](https://prod.superblogcdn.com/site_cuid_cm5qst7v3003gwirgwqtxn8i8/images/2022-10-10t184447z2lynxmpei990xyrtroptp4bio-rad-m-a-qiagen-1736815056257-compressed.jpg)

(Reuters) -California-based diagnostics company Bio-Rad Laboratories is in talks to merge with Qiagen NV, the Wall Street Journal reported on Monday, citing people familiar with the matter.

Talks between the two companies have been going on for a while but an agreement is unlikely for another few weeks, the report said.

U.S-listed shares of Qiagen rose 8% while Bio-Rad fell [nearly 10% after the report](https://www.financedigest.com/flood-most-damaging-peril-of-2016-causing-nearly-one-third-of-210bn-global-economic-losses-according-to-aon-catastrophe-report.html "Flood most damaging peril of 2016, causing nearly one-third of 0bn global economic losses – according to Aon catastrophe report").

Bio Rad, which manufactures and supplies products such as laboratory apparatus, instruments and diagnostics, has a market-cap of $12.85 billion.

Both Qiagen and Bio-Rad did not immediately respond to Reuters’ requests for comments.

According to the WSJ report, a deal between the two companies could be worth more than $10 billion, making it one of the [biggest in the healthcare testing domain after Illumina Inc’s $8-billion takeover of cancer-testing firm](https://www.financedigest.com/uk-firms-plan-biggest-pay-rises-since-2012-to-fill-staff-gaps.html "UK firms plan biggest pay rises since 2012 to fill staff gaps") Grail.

Lab equipment supplier Thermo Fisher Scientific in 2020 made a 11.3-billion-euro bid to acquire Qiagen, which fell through after Qiagen shareholders rejected the offer following a [hedge fund’s](https://www.financedigest.com/what-is-a-hedge-fund.html "What Is A Hedge Fund") campaign.

(Reporting by Bhanvi Satija in Bengaluru;Editing by Vinay Dwivedi)


---
This blog is powered by Superblog. Visit https://superblog.ai to know more.
---